Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDJyong Biotech Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/30/2025 | Q4 2025 | N/A | -$0.05 | N/A | N/A | $0 |
| 06/29/2025 | Q2 2025 | N/A | -$0.02 | N/A | N/A | $0 |
| 12/31/2024 | Q4 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.02 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Jyong Biotech Ltd. Earnings: FAQ's
The conference call for Jyong Biotech Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Jyong Biotech Ltd.'s latest earnings report can be read online.
Jyong Biotech Ltd. (:MENS) has a recorded net income of $-4,671,000.Jyong Biotech Ltd. has generated $-0.064 earnings per share over the last four quarters.
Jyong Biotech Ltd. (:MENS) has a price-to-earnings ratio of -25.04 and price/earnings-to-growth ratio is 0.52.